Micro Emerging Active

Thermo Fisher Scientific Q2 earnings climb

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
4
Sources
2

Top Movers

TickerSectorChange
TMO
Healthcare+8.1%

Sentiment Timeline

Sector Performance

Event Timeline

Aug 02, 2026
Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a … Bullish
Jul 29, 2026
Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the … Bullish
Jul 25, 2026
Thermo Fisher (TMO) Climbs 8.7% on Solid Earnings, Price Target Upgrades Bullish
Jul 23, 2026
Thermo Fisher Scientific Q2 Income Climbs Neutral

Related Articles

Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?

Yahoo Finance · Aug 02, 2026
Mixed
🤖

AI Overview

What happened: On July 23, Edwards Lifesciences (EW) reported Q2 2026 net sales of $1.74 billion, up 13.6% YoY, beating estimates. Thermo Fisher Scientific (TMO) saw its share prices surge 8.71% on July 28, following strong Q2 earnings of $1.736 billion, or $4.68 per share, up from $1.617 billion, or $4.28 per share, in Q2 2025.

Market impact: The robust earnings from Edwards Lifesciences and Thermo Fisher Scientific drove investor confidence in the healthcare sector, particularly in medical devices and scientific research. This positively impacted related companies and pushed up their stock prices.

What to watch next: On August 11, Edwards Lifesciences is set to release its Q2 earnings report, which could provide further insights into its growth trajectory. Additionally, investors await Thermo Fisher Scientific's Q3 earnings, scheduled for October 26, to gauge the sustainability of its strong performance.
AI Overview as of Jul 29, 2026

Timeline

First SeenAug 02, 2026
Last UpdatedAug 22, 2026